AMRX vs CLOV
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AMRX and CLOV stock pages for the full models.
Not investment advice.